» Articles » PMID: 38317306

Five Decades of the Use of Botulinum Toxin in Ophthalmology

Overview
Specialty Ophthalmology
Date 2024 Feb 6
PMID 38317306
Authors
Affiliations
Soon will be listed here.
Abstract

Botulinum toxin (BoNT) has been known for over 50 years. It has conquered many areas of medicine and has become indispensable in contemporary medicine. Now, BoNT is used to treat at least 26 conditions in six medical specialties. Although the use of BoNT began in strabology, it became the gold standard for many ophthalmologic pathologies. The present review of the literature focuses on the use of BoNT in ophthalmology and treatment of the following conditions: blepharospasm, facial hemispasm, facial palsy, spastic entropion, strabismus, endocrine orbitopathy, convergence spasm, and facial trauma. We conclude that nearly half a century of experience in utilizing BoNT in ophthalmology ensured a satisfactory level of effectiveness and safety for patients with many pathologies. Areas of future research include the application of BoNT in new selected indications, the development of the route of application without injections, and the development of long-acting BoNT forms for patients who require repeated long-term treatment.

References
1.
Deka A, Saikia S . Botulinum toxin for lower lid entropion correction. Orbit. 2011; 30(1):40-2. DOI: 10.3109/01676830.2010.544443. View

2.
Rohrbach S, Junghans K, Kohler S, Laskawi R . Minimally invasive application of botulinum toxin A in patients with idiopathic rhinitis. Head Face Med. 2009; 5:18. PMC: 2770996. DOI: 10.1186/1746-160X-5-18. View

3.
Girard B, Piaton J, Keller P, Abadie C, Nguyen T . Botulinum neurotoxin injection for the treatment of epiphora in nasolacrimal duct obstruction. J Fr Ophtalmol. 2017; 40(8):661-665. DOI: 10.1016/j.jfo.2017.03.006. View

4.
Scorr L, Cho H, Kilic-Berkmen G, McKay J, Hallett M, Klein C . Clinical Features and Evolution of Blepharospasm: A Multicenter International Cohort and Systematic Literature Review. Dystonia. 2022; 1. PMC: 9557246. DOI: 10.3389/dyst.2022.10359. View

5.
Falzon K, Galea M, Cunniffe G, Logan P . Transconjunctival botulinum toxin offers an effective, safe and repeatable method to treat gustatory lacrimation. Br J Ophthalmol. 2010; 94(3):379-80. DOI: 10.1136/bjo.2008.155887. View